Strides Pharma Science Ltd.
NSE: STAR | BSE: 532531
₹1,153.60
₹2.20
(0.19%)
As on 19-May-2026IST
Market cap
₹10,634 Cr
Revenue (TTM)
₹4,859 Cr
P/E Ratio
19.1
P/B Ratio
3.4
Div. Yield
0.4 %
Quality Score
2/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹556 Cr
-
ROE
17.5 %
-
ROCE
16.6 %
-
Industry P/E
30.79
-
EV/EBITDA
11.2
-
Debt to Equity
0.2
-
Book Value
₹337.1
-
EPS
₹62.8
-
Face value
10
-
Shares outstanding
92,172,714
10 Years Aggregate
CFO
₹2,466.77 Cr
EBITDA
₹4,462.43 Cr
Net Profit
₹408.87 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Strides Pharma
| 28.1 | 15.3 | 31.5 | 74.4 | 53.3 | 10.1 | 2.0 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Strides Pharma
| 27.8 | 0.8 | 85.6 | -21.7 | -49.3 | 142.9 | -22.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Strides Pharma
|
1,153.6 | 10,633.5 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
| 3,248.2 | 40,546.6 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.4 | 9.0 | |
| 557.4 | 1,613.8 | 502.6 | 57.9 | 13.8 | 18.2 | 27.9 | 4.4 | |
| 282.8 | 2,994.9 | 927.1 | 134.7 | 12.8 | 11.2 | 23.2 | 2.5 | |
| 2,038.2 | 15,490.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.2 | 4.3 | |
| 2,171.6 | 34,908.7 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.2 | 8.4 | |
| 2,000.7 | 2,073.7 | 503.1 | 67.3 | 19.6 | 21.9 | 30.8 | 6.8 | |
| 4,785.4 | 21,859.4 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.3 | 5.2 | |
| 766.8 | 1,706.1 | 251.7 | 30.5 | 18.0 | 9.7 | 56 | 5.3 | |
| 3,230.9 | 7,449.8 | 1,773.8 | 309.8 | 24.0 | 43.1 | 24 | 9.6 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Jugal Harpalani
1 min read•By Research Desk
About Strides Pharma
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The... company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India. Read more
-
Incorporated
1990
-
Chairman
Arun Kumar
-
Managing Director
Badree Komandur
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsRotation Of Statutory Auditors In FY28
18-May-2026Corporate Action-Board approves Dividend
18-May-2026No News & Announcements are available.
FAQs for Strides Pharma
What is the current share price of Strides Pharma Science Ltd Today?
The share price of Strides Pharma Science Ltd is ₹1,153.60 (NSE) and ₹1,153.65 (BSE) as of 19-May-2026 IST. Strides Pharma Science Ltd has given a return of 53.27% in the last 3 years.
What is the current PB & PE ratio of Strides Pharma Science Ltd?
The P/E ratio of Strides Pharma Science Ltd is 19.12 times as on 19-May-2026, a 38 discount to its peers’ median range of 30.79 times.
The P/B ratio of Strides Pharma Science Ltd is 3.42 times as on 19-May-2026, a 27 discount to its peers’ median range of 4.66 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
1.72
|
2.42
|
|
2024
|
0.00
|
3.39
|
|
2023
|
0.00
|
1.18
|
|
2022
|
0.00
|
1.32
|
|
2021
|
28.21
|
2.73
|
What is the 52 Week High and Low of Strides Pharma Science Ltd?
The 52-week high and low of Strides Pharma Science Ltd are Rs 1,231.00 and Rs 660.05 as of 20-May-2026.
What is the market cap of Strides Pharma Science Ltd?
Strides Pharma Science Ltd has a market capitalisation of ₹ 10,634 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Strides Pharma Science Ltd?
Before investing in Strides Pharma Science Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.